Autophagy in hepatic adaptation to stress
Artículo
Open/ Download
Access note
Acceso Abierto
Publication date
2020
Author
Abstract
Autophagy is an evolutionarily ancient process whereby eukaryotic cells eliminate disposable or potentially dangerous cytoplasmic material, to support bioenergetic metabolism and adapt to stress. Accumulating evidence indicates that autophagy operates as a critical quality control mechanism for the maintenance of hepatic homeostasis in both parenchymal (hepatocytes) and non-parenchymal (stellate cells, sinusoidal endothelial cells, Kupffer cells) compartments. In line with this notion, insufficient autophagy has been aetiologically involved in the pathogenesis of multiple liver disorders, including alpha-1-antitrypsin deficiency, Wilson disease, non-alcoholic steatohepatitis, liver fibrosis and hepatocellular carcinoma. Here, we critically discuss the importance of functional autophagy for hepatic physiology, as well as the mechanisms whereby defects in autophagy cause liver disease.
Patrocinador
Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT), CONICYT FONDECYT: 3180427, 1140549, 1180186.
Breakthrough Level 2 grant from the US DoD, Breast Cancer Research Program (BCRP): BC180476P1.
Dept. of Radiation Oncology at Weill Cornell Medicine (New York, US).
Lytix (Oslo, Norway).
Phosplatin (New York, US).
Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT), CONICYT FONDAP: 15150012.
Takeda Pharmaceutical Company Ltd. P09-015-F.
European Commission RD MSCA-RISE: 734749.
Michael J Fox Foundation for Parkinson's Research - Target Validation grant: 9277.
FONDEF: ID16I10223, D11E1007.
Office of Naval Research: N62909-16-1-2003.
United States Department of Defense, Air Force Office of Scientific Research (AFOSR): FA9550-16-1-0384.
ALSRP Therapeutic Idea Award: AL150111.
Muscular Dystrophy Association: 382453.
CONICYT Brazil: 441921/2016-7.
Ligue contre le Cancer (equipe labellisee).
French National Research Agency (ANR).
French National Research Agency (ANR).
Fondation ARC pour la Recherche sur le Cancer.
Region Ile-de-France.
Chancelerie des universites de Paris (Legs Poix), Fondation pour la Recherche Medicale (FRM)
European Research Area Network on Cardiovascular Diseases (ERACVD, MINOTAUR)
Gustave Roussy Odyssea, the European Union Horizon 2020 Project Oncobiome
Fondation Carrefour
Institut National du Cancer (INCA) France: GDW20171100085, GDW20181100051.
Inserm (HTE).
Inserm Transfert, Institut Universitaire de France.
Leducq Foundation.
LabEx Immuno-Oncology.
RHU Torino Lumiere.
Seerave Foundation.
SIRIC Stratified Oncology Cell DNA Repair and Tumor Immune Elimination (SOCRATE).
SIRIC Cancer Research and Personalized Medicine (CARPEM).
Indexation
Artículo de publicación ISI Artículo de publicación SCOPUS
Quote Item
Journal of Hepatology 2020 vol. 72 / 183–196
Collections
The following license files are associated with this item: